Gerardo Musuraca, MD, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy, outlines the Italian perspective of the diagnosis, treatment, and management of diffuse large B-cell lymphoma (DLBCL) including understanding molecular alterations involved in the pathogenesis of disease. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

свернуть